Adams Respiratory to Be Acquired for $2.3 Billion

Drug maker Adams Respiratory Therapeutics Inc., maker of Mucinex, said Monday it would be acquired by Reckitt Benckiser Group for $2.3 billion, as the household-products company seeks to broaden its footprint in consumer healthcare.
MarketWatch